Targeting ABL kinases overcomes melanoma immune evasion following resistance to MAPK inhibition. (nature.com)

Authors: Tripathi R … Plattner R Journal: Nature Communications Published: 2026-08-21 DOI: https://doi.org/10.1038/s41467-026-76864-y